Loading clinical trials...
Loading clinical trials...
Craving is defined as an irrepressible urge to consume certain products and represents one of the key factors in severe substance use disorders, as illustrated by its recent inclusion as a diagnostic ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Laval University
Collaborators
NCT07478510 · ARFID, Anorexia Nervosa, and more
NCT05540704 · Type 1 Diabetes, Eating Disorders, and more
NCT05995496 · Bulimia Nervosa
NCT05614024 · Bulimia Nervosa
NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more
Centre d'expertise Poids, Image et Alimentation (CEPIA)
Québec
IUCPQ
Québec
Université de Nantes
Nantes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions